SCHEMBL24254589

SCHEMBL24254589

CN(C)Sc1ccc(NCc2ccccc2)c(N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.43
BACE1 P56817 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPT P10636 2/20 0.39
ASPH Q12797 1/20 0.39
RIOX2 Q8IUF8 1/20 0.39
KDM8 Q8N371 1/20 0.39
CYP2D6 P10635 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
IDO1 P14902 1/20 0.39
HPGD P15428 2/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29353516 0.76 HDAC6 (0.68) HDAC6BACE1MEN1KMT2ACYP1A2
SCHEMBL1040774 0.76 HDAC6 (0.68) HDAC6BACE1MEN1KMT2ACYP1A2
SCHEMBL24254528 0.73 ALDH1A1 (0.50) MEN1KMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL3235742 0.73 SMN1; SMN2 (0.47) HDAC6BACE1MEN1KMT2ACYP1A2
SCHEMBL11274390 0.73 PKM (0.52) HDAC6BACE1HSD17B10KDM4EMAPT
SCHEMBL15311091 0.73 MAPT (0.44) HDAC6BACE1MEN1KMT2ACYP1A2
SCHEMBL29922357 0.71 BACE1 (0.65) HDAC6BACE1MEN1KMT2ACYP1A2
SCHEMBL396451 0.71 BACE1 (0.65) HDAC6BACE1MEN1KMT2ACYP1A2
SCHEMBL13374030 0.71 GLA (0.49) MEN1KMT2ACYP1A2CYP3A4CYP2C9
SCHEMBL14074467 0.70 NAMPT (0.44) MEN1KMT2AMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed